Ronna Sue Cohen Buys 2,288 Shares of CVS Health Corp (CVS)

Ronna Sue Cohen lifted its stake in shares of CVS Health Corp (NYSE:CVS) by 4.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 59,741 shares of the pharmacy operator’s stock after purchasing an additional 2,288 shares during the quarter. CVS Health comprises about 2.8% of Ronna Sue Cohen’s investment portfolio, making the stock its 6th largest position. Ronna Sue Cohen’s holdings in CVS Health were worth $4,703,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of CVS. Kiley Juergens Wealth Management LLC boosted its position in shares of CVS Health by 41.5% in the 3rd quarter. Kiley Juergens Wealth Management LLC now owns 2,270 shares of the pharmacy operator’s stock worth $178,000 after buying an additional 666 shares in the last quarter. Security National Bank of Sioux City Iowa IA boosted its position in shares of CVS Health by 3.3% in the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 22,523 shares of the pharmacy operator’s stock worth $1,449,000 after buying an additional 720 shares in the last quarter. Twin Capital Management Inc. boosted its position in shares of CVS Health by 0.7% in the 2nd quarter. Twin Capital Management Inc. now owns 108,530 shares of the pharmacy operator’s stock worth $6,984,000 after buying an additional 730 shares in the last quarter. Nissay Asset Management Corp Japan ADV lifted its holdings in CVS Health by 0.6% in the 2nd quarter. Nissay Asset Management Corp Japan ADV now owns 123,260 shares of the pharmacy operator’s stock valued at $7,932,000 after purchasing an additional 753 shares in the last quarter. Finally, Leavell Investment Management Inc. lifted its holdings in CVS Health by 13.1% in the 2nd quarter. Leavell Investment Management Inc. now owns 6,507 shares of the pharmacy operator’s stock valued at $419,000 after purchasing an additional 754 shares in the last quarter. 82.75% of the stock is currently owned by institutional investors and hedge funds.

A number of research analysts have issued reports on the stock. Royal Bank of Canada restated a “buy” rating and issued a $90.00 target price on shares of CVS Health in a report on Wednesday, August 8th. Leerink Swann set a $80.00 target price on shares of CVS Health and gave the company an “outperform” rating in a report on Thursday, August 9th. Morgan Stanley reduced their target price on shares of CVS Health from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Tuesday, July 3rd. Mizuho restated a “buy” rating on shares of CVS Health in a report on Saturday, June 30th. Finally, ValuEngine upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a report on Thursday, October 11th. One research analyst has rated the stock with a sell rating, five have given a hold rating, ten have given a buy rating and two have given a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $86.31.

In other news, EVP Kevin Hourican sold 8,564 shares of the stock in a transaction dated Monday, August 27th. The shares were sold at an average price of $75.00, for a total transaction of $642,300.00. Following the transaction, the executive vice president now directly owns 12,135 shares in the company, valued at approximately $910,125. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Eva C. Boratto sold 13,311 shares of the stock in a transaction dated Monday, September 17th. The stock was sold at an average price of $77.16, for a total transaction of $1,027,076.76. Following the transaction, the executive vice president now owns 55,162 shares in the company, valued at $4,256,299.92. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 43,409 shares of company stock worth $3,392,097. Insiders own 0.53% of the company’s stock.

Shares of CVS stock opened at $74.36 on Thursday. The stock has a market cap of $80.14 billion, a PE ratio of 12.60, a P/E/G ratio of 1.05 and a beta of 1.02. CVS Health Corp has a 1-year low of $60.14 and a 1-year high of $83.88. The company has a debt-to-equity ratio of 1.73, a quick ratio of 1.87 and a current ratio of 2.34.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 8th. The pharmacy operator reported $1.69 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.61 by $0.08. The business had revenue of $46.71 billion for the quarter, compared to analyst estimates of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The company’s revenue was up 2.2% on a year-over-year basis. During the same period in the prior year, the firm posted $1.33 EPS. Analysts forecast that CVS Health Corp will post 7.05 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 1st. Stockholders of record on Wednesday, October 24th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.69%. CVS Health’s payout ratio is currently 33.90%.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Read More: Discount Rate

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply